Supernus announces U.S. FDA approved an update for label for Qelbree
Pharmaceuticals announced that the U.S. Food and Drug Administration, FDA, has approved an update for the label for Qelbree to ...
Investing14d
FDA approves Qelbree label update for ADHD treatment
The new information in Section 12.2 of the label details Qelbree's partial agonist activity at the ... This multimodal pharmacodynamic profile is thought to contribute to the drug's mechanism of ...
Nasdaq14d
Supernus Pharmaceuticals Announces FDA Approval for Updated Qelbree Label Including New Pharmacodynamic Data and Lactation Information
The mechanism of action of Qelbree, though unclear, is thought to be through inhibiting the reuptake of norepinephrine. Additionally, the updated label now includes new lactation data for ...